Serum dihydroxyvitamin d metabolite concentrations in patients on chronic anticonvulsant drug therapy: Response to pharmacologic doses of vitamin D2
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Metabolic Bone Disease and Related Research
- Vol. 5 (1) , 1-6
- https://doi.org/10.1016/0221-8747(83)90043-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Reduced 1,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapyMetabolic Bone Disease and Related Research, 1981
- 6 Drug-induced disorders of vitamin D and mineral metabolismClinics in Endocrinology and Metabolism, 1980
- Effect of phenytoin on bone and vitamin D metabolismAnnals of Neurology, 1979
- Phenytoin: Effects on Calcium Flux and Cyclic NucleotidesEpilepsia, 1977
- Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjectsArchives of Biochemistry and Biophysics, 1977
- A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasmaArchives of Biochemistry and Biophysics, 1976
- The Effect of Anticonvulsant Therapy on Serum Levels of 25-Hydroxy-Vitamin D, Calcium, and Parathyroid HormoneJournal of Clinical Endocrinology & Metabolism, 1975
- Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.BMJ, 1975
- The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.Journal of Clinical Investigation, 1975
- Circulating 25-hydroxyvitamin D in manThe American Journal of Medicine, 1974